155 related articles for article (PubMed ID: 36618070)
1. Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy.
Chen CY; Zheng SY; Cai G; Xu C; Cai R; Li M; Shen KW; Chen XS; Ou D; Qi WX; Cao L; Chen JY
J Oncol; 2022; 2022():4145872. PubMed ID: 36618070
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials.
Qi WX; Cao L; Xu C; Zhao S; Chen J
Breast; 2020 Feb; 49():165-170. PubMed ID: 31812892
[TBL] [Abstract][Full Text] [Related]
3. Regional nodal irradiation in pT1-2N1 breast cancer patients treated with breast-conserving surgery and whole breast irradiation.
Park SH; Kim JC
Radiat Oncol J; 2020 Mar; 38(1):44-51. PubMed ID: 32229808
[TBL] [Abstract][Full Text] [Related]
4. Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis.
Moreno AC; Lin YH; Bedrosian I; Shen Y; Stauder MC; Smith BD; Buchholz TA; Babiera GV; Woodward WA; Shaitelman SF
Adv Radiat Oncol; 2017; 2(3):291-300. PubMed ID: 29114595
[TBL] [Abstract][Full Text] [Related]
5. Association Between Regional Nodal Irradiation and Breast Cancer Recurrence-Free Interval for Patients With Low-Risk, Node-Positive Breast Cancer.
Sit D; Lalani N; Chan E; Tran E; Speers C; Gondara L; Chia S; Gelmon K; Lohrisch C; Nichol A
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):861-869. PubMed ID: 34762971
[TBL] [Abstract][Full Text] [Related]
6. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
7. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
Almahariq MF; Quinn TJ; Siddiqui Z; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
Radiother Oncol; 2020 Jan; 142():186-194. PubMed ID: 31615634
[TBL] [Abstract][Full Text] [Related]
8. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
van Maaren MC; de Munck L; Jobsen JJ; Poortmans P; de Bock GH; Siesling S; Strobbe LJA
Breast Cancer Res Treat; 2016 Dec; 160(3):511-521. PubMed ID: 27730424
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.
Wan Q; Su L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
JAMA Netw Open; 2021 Apr; 4(4):e216259. PubMed ID: 33890992
[TBL] [Abstract][Full Text] [Related]
10. Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated.
Leonardi MC; Scognamiglio IR; Maisonneuve P; Dicuonzo S; Rojas DP; Zerella MA; Morra A; Gerardi MA; Zaffaroni M; De Scalzi A; Girardi A; Magnoni F; Montagna E; Fodor CI; Galimberti VE; Veronesi P; Orecchia R; Pacelli R; Jereczek-Fossa BA; Corso G
Breast Cancer Res Treat; 2021 Jul; 188(2):511-524. PubMed ID: 33905020
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
[TBL] [Abstract][Full Text] [Related]
12. Protocol for the postoperative radiotherapy in N1 breast cancer patients (PORT-N1) trial, a prospective multicenter, randomized, controlled, non-inferiority trial of patients receiving breast-conserving surgery or mastectomy.
Lee TH; Chang JH; Jang BS; Kim JS; Kim TH; Park W; Kim YB; Kim SS; Han W; Lee HB; Shin KH
BMC Cancer; 2022 Nov; 22(1):1179. PubMed ID: 36384573
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term results between radiotherapy after breast-conserving surgery and postmastectomy radiotherapy in stage T1-2N1M0 breast cancer.
Lan XW; Wen G; He Z; Huang JH; Zou XB; Lin X; Tan YT; Huang XB
Cancer Manag Res; 2019; 11():6477-6487. PubMed ID: 31372049
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
15. Is There a Role for Post-Mastectomy Radiotherapy for T1-2N1 Breast Cancers With Node-Positive Pathology After Patients Become Node-Negative Pathology Following Neoadjuvant Chemotherapy?
Wang Q; Zhao J; Han X; Er P; Meng X; Shi J; Sun H; Zhu J; Zhu L; Wu S; Zhang W; Sun B
Front Oncol; 2020; 10():892. PubMed ID: 32695661
[No Abstract] [Full Text] [Related]
16. Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion.
Li C; Yang Y; Wang J; Jin K; Yang Z; Yu X; Guo X; Chen X
Cancer Med; 2021 Oct; 10(20):7203-7212. PubMed ID: 34547183
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and toxicity following post-operative hypofractionated radiotherapy to the regional nodes and the breast or the chest wall in locally advanced breast cancer.
Tramacere F; Arcangeli S; Colciago RR; Lucchini R; Pati F; Portaluri M
Br J Radiol; 2022 Jul; 95(1135):20211299. PubMed ID: 35522785
[TBL] [Abstract][Full Text] [Related]
18. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
Front Oncol; 2022; 12():789198. PubMed ID: 35280719
[TBL] [Abstract][Full Text] [Related]
19. Breast-conserving therapy is safe both within
Huang X; Cai XY; Liu JQ; Hao WW; Zhou YD; Wang X; Xu Y; Chen C; Lin Y; Wang CJ; Song Y; Sun Q
Gland Surg; 2020 Jun; 9(3):775-787. PubMed ID: 32775268
[TBL] [Abstract][Full Text] [Related]
20. Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases.
Corradini S; Reitz D; Pazos M; Schönecker S; Braun M; Harbeck N; Matuschek C; Bölke E; Ganswindt U; Alongi F; Niyazi M; Belka C
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30709048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
